TGen News & Press Releases

TGen identifies immune effects of a drug in aggressive ovarian cancer that strikes young women

Posted Friday July 10, 2020

SP-2577 could enable the immune system to attack ovarian cancer; clinical trials for patients expected soon

TGen-led study identifies unique cells that may drive lung fibrosis

Posted Wednesday July 8, 2020

Study with Vanderbilt University shows how the body’s attempts to repair damage may instead contribute to severe lung disease

TGen teams with Poba Medical to produce 10,000 COVID-19 test kits per month

Posted Thursday July 2, 2020

Poba Medical’s cleanroom assembly line helps TGen provide coronavirus tests for some of Arizona’s most vulnerable and underserved populations

Study led by TGen and City of Hope shows new way of identifying tumor response to immunotherapy

Posted Monday June 22, 2020

Findings could improve personalized medicine for cancer patients

TGen’s Ashion Analytics® and HonorHealth show how ‘organoids’ can help pinpoint the right therapies for cancer patients

Posted Monday June 22, 2020

New PATRIOT analysis unveiled at this week’s AACR meeting; builds on Ashion’s GEM-ExTra program, providing unprecedented accuracy in prescribing anti-cancer treatments

Ancient DNA found in isolated villages harbor immune properties that might benefit humanity today

Posted Monday June 15, 2020

TGen-led international study traces genetic diversity among hunter-gathers of Indonesia, including last significant vestige of DNA from extinct human cousins

TGen’s Ashion Analytics certified for NCI’s MATCH cancer clinical trials